切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2026, Vol. 20 ›› Issue (05) : 485 -490. doi: 10.3877/cma.j.issn.1673-9248.2026.05.002

指南与规范

《急性缺血性卒中血管内治疗技术中国专家共识2025》述评:迈向精准化与规范化
陈勇1, 彭淼2, 裴月红1, 黄骁1, 张淦1, 王文景1, 杨琼1,†()   
  1. 1 100191 北京大学第三医院神经内科
    2 618000 四川德阳,德阳市人民医院神经内科
  • 收稿日期:2026-07-24 出版日期:2026-10-01
  • 通信作者: 杨琼
  • 基金资助:
    国家自然科学基金项目(81901204)

Commentary on the Chinese expert consensus on endovascular treatment technology for acute ischemic stroke 2025: toward precision and standardization

Yong Chen1, Miao Peng2, Yuehong Pei1, Xiao Huang1, Gan Zhang1, Wenjing Wang1, Qiong Yang1,†()   

  1. 1 Department of Neurology, Peking University Third Hospital, Beijing 100191, China
    2 Department of Neurology, Deyang People's Hospital, Deyang 618000, China
  • Received:2026-07-24 Published:2026-10-01
  • Corresponding author: Qiong Yang
引用本文:

陈勇, 彭淼, 裴月红, 黄骁, 张淦, 王文景, 杨琼. 《急性缺血性卒中血管内治疗技术中国专家共识2025》述评:迈向精准化与规范化[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(05): 485-490.

Yong Chen, Miao Peng, Yuehong Pei, Xiao Huang, Gan Zhang, Wenjing Wang, Qiong Yang. Commentary on the Chinese expert consensus on endovascular treatment technology for acute ischemic stroke 2025: toward precision and standardization[J/OL]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2026, 20(05): 485-490.

血管内治疗(EVT)已经成为大血管闭塞性急性脑卒中的标准治疗方案,中国神经介入领域在近十年间实现了跨越式发展。《急性缺血性卒中血管内治疗中国指南2023》的发布奠定了循证医学基础,而《急性缺血性卒中血管内治疗技术中国专家共识2025》(简称“共识”)的发布,标志着我国EVT领域进一步向“技术精细化”和“操作规范化”的纵深迈进。本文基于共识的核心内容,结合最新循证医学证据,从共识亮点、血管通路选择、取栓技术优化、病因导向策略、中等血管闭塞取栓、挑战与展望6个方面进行述评,以便明确该共识的实践价值及未来该领域的进一步发展方向。

Endovascular treatment (EVT) has become the standard treatment for acute ischemic stroke caused by large vessel occlusion, and the field of neurointervention in China has achieved rapid development in the past decade. The publication of the "Chinese guidelines for endovascular treatment of acute ischemic stroke 2023" laid the evidence-based foundation for this field, while the publication of the "Chinese expert consensus on endovascular treatment techniques for acute ischemic stroke 2025" (hereinafter referred to as the "Consensus") marks a further step towards "technical refinement" and "operational standardization" in the field of EVT in China. Based on the core content of the Consensus and combined with the latest evidence, this article reviews and comments on six aspects: consensus highlights, vascular access selection, optimization of thrombectomy techniques, etiology-directed strategies, thrombectomy for medium vessel occlusion, and challenges and prospects, in order to clarify the practical value of the consensus and the future development direction of this field.

1
Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke [J]. N Engl J Med, 2015, 372(1): 11-20.
2
Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection [J]. N Engl J Med, 2015, 372(11): 1009-1018.
3
Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke [J]. N Engl J Med, 2015, 372(11): 1019-1030.
4
Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke [J]. N Engl J Med, 2015, 372(24): 2296-2306.
5
Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke [J]. N Engl J Med, 2015, 372(24): 2285-2295.
6
中国卒中学会神经介入分会. 急性缺血性卒中血管内治疗技术中国专家共识2025 [J]. 中国卒中杂志, 2025, 20(11): 1428-1459.
7
中国卒中学会, 中国卒中学会神经介入分会, 中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2023 [J]. 中国卒中杂志, 2023, 18(6): 684-711.
8
de Havenon A, Zaidat OO, Amin-Hanjani S, et al. Large vessel occlusion stroke due to intracranial atherosclerotic disease: identification, medical and interventional treatment, and outcomes [J]. Stroke, 2023, 54(6): 1695-1705.
9
Al Kasab S, Nguyen TN, Derdeyn CP, et al. Emergent large vessel occlusion due to intracranial stenosis: identification, management, challenges, and future directions [J]. Stroke, 2024, 55(2): 355-365.
10
Zaidat OO, Castonguay AC, Linfante I, et al. First pass effect: a new measure for stroke thrombectomy devices [J]. Stroke, 2018, 49(3): 660-666.
11
Gupta R, Saver JL, Levy E, et al. New class of radially adjustable stentrievers for acute ischemic stroke: primary results of the multicenter TIGER trial [J]. Stroke, 2021, 52(5): 1534-1544.
12
Tomasello A, Moreu M, Terceno M, et al. Randomized study comparing first-line dual versus single-stent retriever technique: TWIN2WIN [J]. Stroke, 2025, 56(2): 326-334.
13
Nguyen TN, Dabus G, McGuinness B, et al. SUMMIT MAX: a randomized trial of the super large bore HiPoint reperfusion system versus Vecta system for aspiration thrombectomy [J]. Stroke, 2025, 56(8): 1980-1990.
14
Lapergue B, Blanc R, Costalat V, et al. Effect of thrombectomy with combined contact aspiration and stent retriever vs stent retriever alone on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER2 randomized clinical trial [J]. JAMA, 2021, 326(12): 1158-1169.
15
Mokin M, Setlur Nagesh SV, Ionita CN, et al. Stent retriever thrombectomy with the cover accessory device versus proximal protection with a balloon guide catheter: in vitro stroke model comparison [J]. J Neurointerv Surg, 2016, 8(4): 413-417.
16
Zaidat OO, Mueller-Kronast NH, Hassan AE, et al. Impact of balloon guide catheter use on clinical and angiographic outcomes in the STRATIS stroke thrombectomy registry [J]. Stroke, 2019, 50(3): 697-704.
17
Liu J, Zhou Y, Zhang L, et al. Balloon guide catheters for endovascular thrombectomy in patients with acute ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial [J]. Lancet, 2024, 404(10468): 2165-2174.
18
Dhillon PS, Butt W, Podlasek A, et al. Effect of proximal blood flow arrest during endovascular thrombectomy (ProFATE): a multicenter, blinded-end point, randomized clinical trial [J]. Stroke, 2025, 56(2): 371-379.
19
Karayi G, Feler JR, Kim R, et al. Balloon guide catheters improve first-pass effect and neurologic outcomes in mechanical thrombectomy: a matched cohort analysis [J/OL]. J Neurointerv Surg, 2026-05-07 (2026-07-23).
20
Sun X, Deng Y, Zhang Y, et al. Balloon angioplasty vs medical management for intracranial artery stenosis: the BASIS randomized clinical trial [J]. JAMA, 2024, 332(13): 1059-1069.
21
Gao F, Tong X, Wei M, et al. Bailout intracranial angioplasty or stenting after thrombectomy for acute large vessel occlusion: 1-year outcomes of ANGEL-REBOOT [J]. Circulation, 2025, 152(20): 1397-1407.
22
Lin L, Liu F, Yi T, et al. Tirofiban on first-pass recanalization in acute stroke endovascular thrombectomy: the OPTIMISTIC randomized clinical trial [J]. JAMA Netw Open, 2025, 8(4): e255308.
23
Huang H, Xu S, Qin T, et al. Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial [J]. Lancet, 2026, 408(10551): 263-274.
24
Romoli M, Molina CA, Zapata-Arriaza E, et al. Emergent carotid stenting for acute anterior circulation ischemic stroke with tandem lesions: the multicenter CERES-TANDEM study [J]. Neurology, 2026, 106(2): e214528.
25
Al Kasab S, Nguyen TN, Abdalkader M, et al. PICASSO (proximal internal carotid artery acute stroke secondary to tandem lesion or local occlusion) thrombectomy randomized trial: study protocol and rationale [J]. Stroke Vasc Interv Neurol, 2025, 5(5): e001690.
26
中国卒中学会神经介入分会. 急性缺血性卒中中等血管闭塞管理中国专家共识2024 [J]. 中国卒中杂志, 2024, 19(11): 1333-1358.
27
Goyal M, Ospel JM, Ganesh A, et al. Endovascular treatment of stroke due to medium-vessel occlusion [J]. N Engl J Med, 2025, 392(14): 1385-1395.
28
Psychogios M, Brehm A, Ribo M, et al. Endovascular treatment for stroke due to occlusion of medium or distal vessels [J]. N Engl J Med, 2025, 392(14): 1374-1384.
29
Clarencon F, Bala F, Baptiste A, et al. Mechanical thrombectomy in ischemic stroke with a medium or distal arterial occlusion: the DISCOUNT randomized clinical trial [J/OL]. JAMA, 2026-07-22 (2026-07-23).
30
Hu W, Jing X, Chen Z, et al. Endovascular treatment of medium-vessel-occlusion strokes [J]. N Engl J Med, 2026, 394(19): 1894-1904.
31
Guenego A, Mine B, Bonnet T, et al. Thrombectomy for distal medium vessel occlusion with a new generation of Stentretriever (Tigertriever 13) [J]. Interv Neuroradiol, 2022, 28(4): 444-454.
32
Mack W, De Leacy RA, Grossberg JA, et al. Stroke thrombectomy with a novel reperfusion system including a 0.088'' aspiration catheter: the imperative trial [J]. J Neurointerv Surg, 2026, 18(5): 1202-1209.
33
Khatri P, Kleindorfer DO, Devlin T, et al. Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial [J]. JAMA, 2018, 320(2): 156-166.
34
Frol S, Zupan M, Chapot R, et al. Distal thrombectomy reconsidered: lessons from DISTALS and ORIENTAL-MEVO [J/OL]. Clin Neuroradiol, 2026-04-21 (2026-07-23).
[1] 国产腔镜手术机器人系统的临床应用解决方案研究项目专家组. 单孔机器人肾上腺切除术专家共识[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(05): 491-497.
[2] 中国肺癌防治联盟, 重庆市老年学和老年医学学会. CT引导下经皮肺穿刺活检围术期规范化管理专家共识[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(04): 525-533.
[3] 世界华人医师协会妇产科分会. 机器人辅助经阴道自然腔道妇科内镜手术专家共识(2026年版)[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(04): 193-200.
[4] 张玲, 陈慧琳, 贾宁阳. 《血管包裹肿瘤簇在肝细胞癌影像诊疗中的临床应用专家共识(2026年版)》解读[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(04): 289-293.
[5] 中国抗癌协会食管癌专业委员会. 食管癌术后辅助治疗专家共识(2026版)[J/OL]. 中华胸部外科电子杂志, 2026, 13(03): 165-180.
[6] 李若曼, 王帆, 张涛. ASPECTS联合表观弥散系数对急性缺血性脑卒中静脉溶栓预后的预测价值[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 403-410.
[7] 张爽, 谢琦, 杨清武. 急性缺血性脑卒中无效再通的研究进展及脑保护新策略[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 351-358.
[8] 戴荣源, 裴月红, 孙庆利, 黄骁, 张淦, 樊东升, 傅瑜. 美国心脏协会/美国卒中协会《2026年急性缺血性脑卒中患者早期管理指南》更新概述[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 359-364.
[9] 曾陈颖, 陈云清, 徐祖兵, 余求龙, 林晶, 洪道俊, 涂琪. 炎症标志物在大梗死核心与非大梗死核心急性缺血性脑卒中行血管内治疗的预后价值[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 372-379.
[10] 魏宸铭, 牟婧宇, 赵心怡, 陈乐, 武剑. 不同评分量表对前循环大血管闭塞性脑卒中诊断预测性能的差异[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 380-388.
[11] 康志霞, 班玉霞, 白如玉, 郝美美, 李正正, 苏琴琴. 血浆致动脉硬化指数和程序性细胞死亡因子4预测急性缺血性脑卒中神经功能缺损及预后的价值[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 389-395.
[12] 胡琼丹, 侯善兵, 陈霞, 王教媛, 戴晓熹. 应激性血糖升高比值预测急性缺血性脑卒中静脉溶栓预后的价值[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 396-402.
[13] 周英, 李文雯, 周钰, 李炜, 贺思怡, 夏海艳, 王海玲. 基于临床医护人员视角的急性缺血性脑卒中患者就医延迟成因与对策的质性研究[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 446-454.
[14] 黄开来, 李威, 赵振强. 依达拉奉右莰醇在急性缺血性脑卒中的临床应用进展[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 455-461.
[15] 中国卒中学会遗传学分会. 肯尼迪病诊断和管理中国专家共识2025[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(03): 240-249.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?